Literature DB >> 25702772

Bedaquiline.

Sebastiaan C Goulooze1, Adam F Cohen1,2, Robert Rissmann1,2.   

Abstract

Entities:  

Keywords:  bedaquiline; multidrug-resistant tuberculosis; therapeutic use

Mesh：

Substances：

Year:  2015        PMID： 25702772      PMCID： PMC4541965          DOI： 10.1111/bcp.12613

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

Review 1.  TMC207: the first compound of a new class of potent anti-tuberculosis drugs.

Authors:  Alberto Matteelli; Anna Cc Carvalho; Kelly E Dooley; Afranio Kritski
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

Review 2.  Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis.

Authors:  Mageshwaran Lakshmanan; Alphienes Stanley Xavier
Journal:  J Young Pharm       Date:  2013-12-30

3.  FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.

Authors:  Edward Cox; Katherine Laessig
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

Review 4.  ATP synthase in mycobacteria: special features and implications for a function as drug target.

Authors:  Ping Lu; Holger Lill; Dirk Bald
Journal:  Biochim Biophys Acta       Date:  2014-02-07

5.  Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

Authors:  Andreas H Diacon; Alexander Pym; Martin P Grobusch; Jorge M de los Rios; Eduardo Gotuzzo; Irina Vasilyeva; Vaira Leimane; Koen Andries; Nyasha Bakare; Tine De Marez; Myriam Haxaire-Theeuwes; Nacer Lounis; Paul Meyvisch; Els De Paepe; Rolf P G van Heeswijk; Brian Dannemann
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

6.  Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue.

Authors:  Anna C Haagsma; Rooda Abdillahi-Ibrahim; Marijke J Wagner; Klaas Krab; Karen Vergauwen; Jerome Guillemont; Koen Andries; Holger Lill; Anil Koul; Dirk Bald
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase.

Authors:  Anna C Haagsma; Ioana Podasca; Anil Koul; Koen Andries; Jerome Guillemont; Holger Lill; Dirk Bald
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240
  7 in total
  1 in total

Review 1.  Phenotypic heterogeneity in persisters: a novel 'hunker' theory of persistence.

Authors:  J Urbaniec; Ye Xu; Y Hu; S Hingley-Wilson; J McFadden
Journal:  FEMS Microbiol Rev       Date:  2022-01-18       Impact factor: 16.408
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.